Clinical Investigation of Infections Due to Leishmanial Parasites
NCT00001169 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 250
Last updated 2008-03-04
Summary
Mechanisms of host immune response to intracellular protozoa will be investigated in patients with naturally acquired infection employing a variety of in-vitro techniques. Both non-specific and antigen-specific humoral and cellular immune responses will be assessed. Parasites will be isolated from patients, cultivated in-vitro, and characterized. Responses to chemotherapy will be assessed parasitologically, immunologically and clinically.
Conditions
- Leishmaniasis
- Leishmaniasis, Visceral
Sponsors & Collaborators
-
National Institute of Allergy and Infectious Diseases (NIAID)
lead NIH
Eligibility
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 1979-12-31
- Completion
- 2001-02-28
Countries
- United States
Study Locations
More Related Trials
-
Evaluation of Less Invasive Procedures for Visceral Leishmaniasis Treatment Efficacy Monitoring Test of Cure
NCT05426577 ·Status: UNKNOWN
-
Spatial Analysis of Host-parasite Interactions in Cutaneous Leishmaniasis in Ethiopia
NCT05332093 ·Status: COMPLETED
-
Topical Sm29 in Combination With Meglumine Antimoniate in the Treatment of Cutaneous Leishmaniasis.
NCT06000514 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Study to Explore Association of Treatment Regimens for Visceral Leishmaniasis, Host Immunological, Genetical and Nutrition Factors With Post-kala-azar Dermal Leishmaniasis (PKDL)
NCT01975051 ·Status: COMPLETED ·Phase: PHASE4
-
Low Antimonial Dosage in American Mucosal Leishmaniasis
NCT01301937 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Prospective Observational Study of Intralesional Treatment With Pentostam in Cutaneous Leishmaniasis Israeli Patients
NCT02281669 ·Status: UNKNOWN
-
LAMP Assay for the Diagnosis of Visceral Leishmaniasis
NCT04003532 ·Status: COMPLETED
-
Safety and Efficacy of Low-Dose Pentavalent Antimony for Treatment of Cutaneous Leishmaniasis
NCT00317980 ·Status: COMPLETED ·Phase: PHASE4
-
Mediterranean Visceral Leishmaniasis With Leishmania Infantum
NCT03784248 ·Status: ACTIVE_NOT_RECRUITING
-
Liposomal Amphotericin in Disseminated Leishmaniasis
NCT02025491 ·Status: COMPLETED ·Phase: PHASE3
-
Add-on Study of Pentoxifylline in Cutaneous Leishmaniasis
NCT01464242 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Single Oral Dose Escalation Study of DNDI-0690 in Healthy Subjects
NCT03929016 ·Status: COMPLETED ·Phase: PHASE1
-
Safety/Efficacy Trial of Killed Leishmania Vaccine in Volunteers With no Response to Leishmanin
NCT00429715 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Intralesional Injection of Metronidazole for the Management of Cutaneous Leishmaniasis
NCT06798415 ·Status: RECRUITING ·Phase: PHASE2
-
Safety Study to Evaluate the Leish-111f + MPL-SE Vaccine in the Prevention of Cutaneous Leishmaniasis in Healthy Subjects Previously Exposed to the Leishmania Parasite
NCT00121849 ·Status: COMPLETED ·Phase: PHASE1
-
Comparison of Standard and Alternative Antimonial Dosage in Patients With American Cutaneous Leishmaniasis
NCT01301924 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Antihelminthic Therapy Combined With Antimony in the Treatment of Cutaneous Leishmaniasis
NCT00469495 ·Status: COMPLETED ·Phase: NA
-
Study to Evaluate the Leish-111F + MPL-SE Vaccine in the Treatment of Cutaneous Leishmaniasis
NCT00111553 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Immunogenicity of a Vaccine for Cutaneous Leishmaniasis Using Recombinant Human Interleukin-12 and Aluminum Hydroxide Gel as Adjuvants
NCT00001906 ·Status: COMPLETED ·Phase: PHASE1
-
The Association of Miltefosine and Pentoxifylline to Treat Mucosal and Cutaneous Leishmaniasis: A Clinical Trial in Brazil
NCT02530697 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Leishmania Antigen Rapid Diagnostic Test Proof-of-Concept and Validation Study
NCT06118749 ·Status: TERMINATED
-
Safety/Efficacy Trial of Killed Leishmania Vaccine in Volunteers With Positive Response to Leishmanin (LST>0)
NCT00429780 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Surveillance for Leishmaniasis Skin Lesions in Mali
NCT00344084 ·Status: COMPLETED
-
Single Infusion of Liposomal Amphotericin B in Indian Visceral Leishmaniasis
NCT00628719 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Evaluate the Leish-111f + MPL-SE Vaccine in Healthy Adults Not Previously Exposed to Leishmania Parasite
NCT00121862 ·Status: COMPLETED ·Phase: PHASE2